Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | phosphatidylinositol 3 and 4 kinase | 0.0037 | 0.0316 | 0.0316 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trypanosoma brucei | target of rapamycin kinase 3, putative | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trypanosoma cruzi | target of rapamycin kinase 3 | 0.0037 | 0.0316 | 0.0978 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0185 | 0.3232 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Schistosoma mansoni | ataxia telangiectasia mutated (atm)-related | 0.0037 | 0.0316 | 1 |
Trypanosoma brucei | FAT domain/Rapamycin binding domain/Phosphatidylinositol 3- and 4-kinase, putative | 0.0023 | 0.0047 | 0.1478 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trypanosoma brucei | Phosphatidylinositol 3-kinase tor1 | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0023 | 0.0047 | 0.1478 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor1 | 0.0037 | 0.0316 | 0.0978 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trypanosoma brucei | phosphatidylinositol 4-kinase, putative | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Toxoplasma gondii | target of rapamycin (TOR), putative | 0.0037 | 0.0316 | 1 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0037 | 0.0316 | 0.0978 |
Trypanosoma cruzi | Phosphatidylinositol 3-kinase tor2 | 0.0037 | 0.0316 | 0.0978 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0037 | 0.0316 | 1 |
Brugia malayi | Phosphatidylinositol 3- and 4-kinase family protein | 0.0037 | 0.0316 | 1 |
Entamoeba histolytica | phosphatidylinositol3-kinaseTor2, putative | 0.0037 | 0.0316 | 1 |
Trypanosoma brucei | phosphatidylinositol 3-related kinase, putative | 0.0037 | 0.0316 | 1 |
Loa Loa (eye worm) | phosphatidylinositol 3 | 0.0037 | 0.0316 | 1 |
Echinococcus multilocularis | FKBP12 rapamycin complex associated protein | 0.0037 | 0.0316 | 0.0316 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0023 | 0.0047 | 0.1478 |
Echinococcus granulosus | FKBP12 rapamycin complex associated protein | 0.0037 | 0.0316 | 0.0316 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trypanosoma brucei | phosphatidylinositol 3-kinase, putative | 0.0037 | 0.0316 | 1 |
Echinococcus granulosus | phosphatidylinositol 3 and 4 kinase | 0.0037 | 0.0316 | 0.0316 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0192 | 0.3371 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Entamoeba histolytica | FKBP-rapamycin associated protein (FRAP), putative | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Schistosoma mansoni | phosphatidylinositol 3-and 4-kinase | 0.0037 | 0.0316 | 1 |
Trypanosoma cruzi | phosphatidylinositol 3-related kinase, putative | 0.0037 | 0.0316 | 0.0978 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Toxoplasma gondii | non-specific serine/threonine protein kinase | 0.0023 | 0.0047 | 0.1478 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Echinococcus multilocularis | DNA dependent protein kinase catalytic subunit | 0.0529 | 1 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Trichomonas vaginalis | PIKK family atypical protein kinase | 0.0037 | 0.0316 | 1 |
Giardia lamblia | GTOR | 0.0037 | 0.0316 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0047 | 0.1478 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
APTT (functional) | = 7.1 ug ml-1 | Tested for anticoagulation effect by Zuchker's activated partial thromboplastin time (APTT) method | ChEMBL. | 8496933 |
IC100 (functional) | = 0.98 ug ml-1 | Tested against HIV-1 induced cytopathic effect in MT-4 cells on LAV-1 strain | ChEMBL. | 8496933 |
IC100 (functional) | = 1.95 ug ml-1 | Tested against HIV-1 induced cytopathic effect in MT-4 cells on KK-1AIDS (strain clinically isolated from an AIDS patient) | ChEMBL. | 8496933 |
IC50 (functional) | = 4.5 ug ml-1 | Tested for cytopathic effect caused by LAV-1 strain in MT-4 cells in the presence of human serum | ChEMBL. | 8496933 |
IC50 (functional) | = 11 ug ml-1 | Tested for cytopathic effect caused by KK-1AIDS strain in MT-4 cells in the presence of human serum | ChEMBL. | 8496933 |
IC50 (functional) | = 12.7 ug ml-1 | Tested for the suppressive effect on giant cell formation in MOLT-4 and MOLT-4/HIV LAV-1 cells (value obtained in the presence of 10% FCS) | ChEMBL. | 8496933 |
IC50 (functional) | = 27.5 ug ml-1 | Tested against HIV-1 replication of KK-1AIDS strain in peripheral blood mononuclear cells (value obtained in the presence of 20% FCS) | ChEMBL. | 8496933 |
TD50 (functional) | > 1000 ug ml-1 | Tested for appearance of MT-4 cell toxicity after 5 days of incubation | ChEMBL. | 8496933 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.